Emili Corbella Selected Research

Peripheral Arterial Disease

3/2007

[Factors predictive of cardiovascular disease in patients with type-2 diabetes and hypercholesterolemia. ESODIAH study].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emili Corbella Research Topics

Disease

7	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2005
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2024 - 07/2011
4	Hypertension (High Blood Pressure) 01/2022 - 07/2010
4	Hypertriglyceridemia 02/2021 - 09/2008
3	Inflammation (Inflammations) 08/2023 - 07/2014
3	Dyslipidemias (Dyslipidemia) 10/2022 - 07/2015
3	Obesity 01/2022 - 03/2007
3	Non-alcoholic Fatty Liver Disease 02/2021 - 11/2019
3	Fatty Liver 01/2020 - 05/2017
3	Acute Coronary Syndrome 01/2018 - 07/2010
3	Coronary Artery Disease (Coronary Atherosclerosis) 07/2010 - 05/2003
2	Weight Loss (Weight Reduction) 01/2024 - 01/2020
2	Body Weight (Weight, Body) 01/2024 - 01/2020
2	Carotid Artery Diseases 08/2023 - 01/2022
2	Insulin Resistance 01/2022 - 01/2020
2	Atherosclerosis 01/2022 - 09/2008
2	Overweight 12/2020 - 08/2020
2	Heart Diseases (Heart Disease) 10/2020 - 01/2018
2	Myocardial Infarction 03/2012 - 03/2007
1	Rheumatoid Arthritis 08/2023
1	Prediabetic State (Prediabetes) 10/2022
1	Pediatric Obesity 01/2022
1	Hyperuricemia 08/2020
1	Type 2 Diabetes Mellitus (MODY) 11/2019
1	Abdominal Obesity 10/2019
1	Cholelithiasis 03/2019
1	Coronary Disease (Coronary Heart Disease) 01/2018
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 07/2015
1	Acute-Phase Reaction 07/2014
1	Angina Pectoris 03/2012
1	Stroke (Strokes) 03/2007
1	Peripheral Arterial Disease 03/2007
1	Hyperhomocysteinemia 01/2005

Drug/Important Bio-Agent (IBA)

7	Triglycerides (Triacylglycerol)IBA 01/2024 - 09/2008
5	LDL CholesterolIBA 01/2024 - 03/2007
5	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 03/2007
5	LipidsIBA 10/2022 - 05/2003
4	Lipoproteins (Lipoprotein)IBA 01/2024 - 07/2014
4	oxidized low density lipoproteinIBA 01/2024 - 07/2010
3	HDL CholesterolIBA 01/2024 - 07/2010
2	HDL LipoproteinsIBA 08/2023 - 07/2014
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2021
2	Apolipoproteins E (ApoE)IBA 01/2022 - 09/2008
2	CholesterolIBA 12/2020 - 09/2008
2	Olive OilIBA 11/2019 - 05/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023
1	AntioxidantsIBA 08/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2022
1	LeptinIBA 01/2022
1	AdiponectinIBA 01/2022
1	GhrelinIBA 01/2022
1	Apolipoproteins B (ApoB)IBA 05/2021
1	Lipoprotein(a)IBA 02/2021
1	purineIBA 08/2020
1	Uric Acid (Urate)IBA 08/2020
1	CarbohydratesIBA 01/2020
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 01/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	Alanine Transaminase (SGPT)IBA 01/2020
1	Dietary Fats (Dietary Fat)IBA 11/2019
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 10/2019
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 03/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 07/2015
1	ApolipoproteinsIBA 09/2008
1	HomocysteineIBA 08/2007
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2007
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2005

Therapy/Procedure

7	Mediterranean Diet 01/2024 - 05/2017
2	Secondary Prevention 10/2020 - 01/2018
1	Therapeutics 10/2022